Targeting SALL4 by entinostat in lung cancer

• Main Authors: Yong, K.J, Li, A, Ou, W.-B, Hong, C.K.Y, Zhao, W, Wang, F, Tatetsu, H, Yan, B, Qi, L, Fletcher, J.A, Yang, H, Soo, R, Tenen, D.G, Chai, L
• Other Authors: BIOCHEMISTRY
• Format: Article
• Published: 2020
• Subjects: entinostat; epidermal growth factor receptor; SALL4 protein; somatomedin C receptor; tumor protein; unclassified drug; antineoplastic agent; benzamide derivative; histone deacetylase inhibitor; pyridine derivative; SALL4 protein, human; small interfering RNA; transcription factor; adult; Article; cancer growth; cancer survival; controlled study; disease activity; drug effect; drug mechanism; drug targeting; female; human; lung cancer; lung carcinogenesis; major clinical study; male; molecular pathology; protein determination; protein expression; protein function; RNA interference; signal transduction; survival rate; animal; antagonists and inhibitors; cell survival; disease model; drug screening; gene expression; genetics; lung tumor; mouse; tumor cell line; Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Gene Expression; Histone Deacetylase Inhibitors; Humans; Lung Neoplasms; Mice; Pyridines; RNA Interference; RNA, Small Interfering; Transcription Factors; Xenograft Model Antitumor Assays
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/174105
• Institution: National University of Singapore

10.18632/oncotarget.12251